Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22.3Revenue $M0.2Net Margin (%)-11,408.5Altman Z-Score-12.3
Enterprise Value $M9.9EPS $-0.1Operating Margin %-13,025.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-11,408.5Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio3.8Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %-0.9Current Ratio4.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-41.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-47.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M248ROIC % (ttm)-138.9Gross Margin Increase y-yN

Gurus Latest Trades with HEB

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

HEB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


HEB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CARTER WILLIAM ACEO, 10% Owner 2015-08-20Buy25,000$0.18-27.78view
CARTER WILLIAM ACEO, 10% Owner 2015-08-18Buy25,000$0.18-27.78view
CARTER WILLIAM ACEO, 10% Owner 2015-08-17Buy25,000$0.18-27.78view
Equels Thomas K.CFO, Pres.,Sec., Vice Chairman 2015-08-14Buy79,104$0.18-27.78view
CARTER WILLIAM ACEO, 10% Owner 2015-04-28Buy100,000$0.24-45.83view
Equels Thomas K.CFO, Vice Chairman, Secretary 2015-04-27Buy100,000$0.24-45.83view
CARTER WILLIAM ACEO, 10% Owner 2015-04-21Buy100,000$0.24-45.83view
Equels Thomas K.CFO, Vice Chairman, Secretary 2015-04-20Buy100,000$0.24-45.83view
CARTER WILLIAM ACEO, 10% Owner 2015-04-17Buy73,681$0.23-43.48view
CARTER WILLIAM ACEO, 10% Owner 2015-04-16Buy26,319$0.23-43.48view

Quarterly/Annual Reports about HEB:

News about HEB:

Articles On GuruFocus.com
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-K/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
Hemispherx Biopharma Inc Reports Operating Results (10-Q) Nov 08 2010 
Weekly CEO Sells Highlight: Hemispherx Biopharma Inc, ADESA Inc, Entergy Corp, and Danaher Corp. Aug 15 2010 
Hemispherx Biopharma Inc Reports Operating Results (10-Q) Aug 06 2010 
Hemispherx Biopharma Inc (HEB) CEO William A Carter buys 500,000 Shares Jul 01 2010 
Weekly CFO Buys Highlight: Wireless Telecom Group, ValueVision Media, American River Bankshares, Hem Dec 12 2009 
Hemispherx Biopharma Inc (HEB) CFO Charles Thomas Iii Bernhardt buys 2,000 Shares Dec 08 2009 

More From Other Websites
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 04 2016
Hemispherx Biopharma Introduces a Voluntary Stock Purchase Plan to Create Shareholder Value Feb 03 2016
Pre-Jonas flooding damages Phila. biotech firm's manufacturing plant Jan 25 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events Jan 22 2016
Hemispherx Biopharma Europe N.V./S.A. : Orphan Medicine Designation and European Medicines Agency... Jan 20 2016
Hemispherx Biopharma Europe N.V./S.A. : Orphan Medicine Designation and European Medicines Agency... Jan 20 2016
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 14 2016
Philadelphia biotech firm discloses stock shares snafu Dec 31 2015
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Dec 16 2015
Hemispherx Biopharma, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 11 2015
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 10 2015
HEMISPHERX BIOPHARMA INC Financials Dec 08 2015
HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Nov 23 2015
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2015 …... Nov 17 2015
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2015 Nov 17 2015
HEMISPHERX BIOPHARMA INC Files SEC form 10-Q, Quarterly Report Nov 16 2015
Hemispherx Biopharma and myTomorrows Collaborate to Make Natural Alpha Interferon Available to... Nov 09 2015
Hemispherx Biopharma, Inc. – Value Analysis (NYSE MKT:HEB) : October 23, 2015 Oct 23 2015
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion on Application for Orphan... Oct 19 2015
New Arrowhead Analyst Issues Updated Diligence and Valuation Report on Hemispherx Biopharma Sep 30 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK